272 related articles for article (PubMed ID: 17147463)
21. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
22. Monitoring drug safety in Astrakhan, Russia.
Kirilochev OO; Dorfman IP; Umerova AR
Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
[TBL] [Abstract][Full Text] [Related]
23. Eurythmy therapy in chronic disease: a four-year prospective cohort study.
Hamre HJ; Witt CM; Glockmann A; Ziegler R; Willich SN; Kiene H
BMC Public Health; 2007 Apr; 7():61. PubMed ID: 17451596
[TBL] [Abstract][Full Text] [Related]
24. Prescribing pattern of Bryophyllum preparations among a network of anthroposophic physicians.
Simões-Wüst AP; Jeschke E; Mennet M; Schnelle M; Matthes H; von Mandach U
Forsch Komplementmed; 2012; 19(6):293-301. PubMed ID: 23343584
[TBL] [Abstract][Full Text] [Related]
25. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcomes of anthroposophic treatment for chronic disease: a four-year follow-up analysis of 1510 patients from a prospective observational study in routine outpatient settings.
Hamre HJ; Kiene H; Glockmann A; Ziegler R; Kienle GS
BMC Res Notes; 2013 Jul; 6():269. PubMed ID: 23849335
[TBL] [Abstract][Full Text] [Related]
27. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database.
Egger T; Dormann H; Ahne G; Runge U; Neubert A; Criegee-Rieck M; Gassmann KG; Brune K
Drugs Aging; 2003; 20(10):769-76. PubMed ID: 12875612
[TBL] [Abstract][Full Text] [Related]
28. Medication Allergy and Adverse Drug Reaction Documentation Discrepancies in an Urban, Academic Emergency Department.
Kiechle ES; McKenna CM; Carter H; Zeymo A; Gelfand BW; DeGeorge LM; Sauter DA; Mazer-Amirshahi M
J Med Toxicol; 2018 Dec; 14(4):272-277. PubMed ID: 29968185
[TBL] [Abstract][Full Text] [Related]
29. Health costs in anthroposophic therapy users: a two-year prospective cohort study.
Hamre HJ; Witt CM; Glockmann A; Ziegler R; Willich SN; Kiene H
BMC Health Serv Res; 2006 Jun; 6():65. PubMed ID: 16749921
[TBL] [Abstract][Full Text] [Related]
30. Drug safety reports on complementary and alternative medicines (ayurvedic and homeopathic medicines) by a spontaneous reporting program in a tertiary care hospital.
Jose J; Rao PG; Kamath MS; Jimmy B
J Altern Complement Med; 2009 Jul; 15(7):793-7. PubMed ID: 19534607
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
32. Use and Safety of Anthroposophic Medicinal Products: An Analysis of 44,662 Patients from the EvaMed Pharmacovigilance Network.
Hamre HJ; Glockmann A; Heckenbach K; Matthes H
Drugs Real World Outcomes; 2017 Dec; 4(4):199-213. PubMed ID: 28965336
[TBL] [Abstract][Full Text] [Related]
33. Probable adverse drug reactions in a rural geriatric nursing home population: a four-year study.
Cooper JW
J Am Geriatr Soc; 1996 Feb; 44(2):194-7. PubMed ID: 8576512
[TBL] [Abstract][Full Text] [Related]
34. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.
Impicciatore P; Choonara I; Clarkson A; Provasi D; Pandolfini C; Bonati M
Br J Clin Pharmacol; 2001 Jul; 52(1):77-83. PubMed ID: 11453893
[TBL] [Abstract][Full Text] [Related]
35. [Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005].
Weisser K; Meyer C; Petzold D; Mentzer D; Keller-Stanislawski B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Nov; 50(11):1404-17. PubMed ID: 17999134
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
[TBL] [Abstract][Full Text] [Related]
37. Adverse drug reactions of non-opioid and opioid analgesics reported to Croatian national authority from 2007 to 2014.
Sunara P; Krnic D; Puljak L
Acta Med Acad; 2017 Nov; 46(2):94-104. PubMed ID: 29338273
[TBL] [Abstract][Full Text] [Related]
38. Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values.
Haffner S; von Laue N; Wirth S; Thürmann PA
Drug Saf; 2005; 28(5):453-64. PubMed ID: 15853446
[TBL] [Abstract][Full Text] [Related]
39. Adverse drug reactions in hospitalised children in Germany are decreasing: results of a nine year cohort-based comparison.
Oehme AK; Rashed AN; Hefele B; Wong IC; Rascher W; Neubert A
PLoS One; 2012; 7(9):e44349. PubMed ID: 23028526
[TBL] [Abstract][Full Text] [Related]
40. [The importance of patient perspective in drug surveillance systems].
Gäwert L; Hierse F; Zink A; Strangfeld A
Z Rheumatol; 2010 Nov; 69(9):795-802. PubMed ID: 21063828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
